| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/09/2000 | WO2000012123A2 Method and measuring device for determining a plurality of analytes in a sample |
| 03/09/2000 | WO1999067291A3 Site specific protein modification by mutagenesis |
| 03/09/2000 | DE19838751A1 Preparing affinity matrix, useful e.g. for purifying antibodies and preparing immunizing peptides, by peptide synthesis on polymeric matrix that is pressure resistant and compatible with water and organic reagents |
| 03/09/2000 | CA2351739A1 Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins |
| 03/09/2000 | CA2351547A1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | CA2341896A1 Support for a method for determining an analyte and a method for producing the support |
| 03/09/2000 | CA2341894A1 Method and device for preparing and/or analyzing biochemical reaction carriers |
| 03/09/2000 | CA2341668A1 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan |
| 03/09/2000 | CA2340865A1 High-affinity antibodies |
| 03/09/2000 | CA2340326A1 Cytotoxic peptides modified by bulky or lipophilic moieties |
| 03/09/2000 | CA2337869A1 Method for labeling biopolymers using isotopes |
| 03/09/2000 | CA2281035A1 Dsba/dsbb/dsbc/dsbd expression plasmid |
| 03/08/2000 | EP0984022A1 Temperature dependent protein purification |
| 03/08/2000 | EP0983351A1 Nucleic acid binding proteins |
| 03/08/2000 | EP0983350A1 Nucleic acid binding proteins |
| 03/08/2000 | EP0983349A1 Nucleic acid binding polypeptide library |
| 03/08/2000 | EP0983298A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin |
| 03/08/2000 | EP0983290A1 Method for producing polymers having nucleo-bases as side-groups |
| 03/08/2000 | EP0983232A2 Guanidinylation reagents |
| 03/08/2000 | CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action |
| 03/08/2000 | CN1246483A Process for extracting nerve growth factor from poisonous snake |
| 03/07/2000 | US6034224 Contacting a somatotropin with a c 10-18 acylglutamate detergent composition and water and adjusting the ph of the somatotropin solution |
| 03/07/2000 | US6034220 Chemical modification of repetitive polymers to enhance water solubility |
| 03/07/2000 | US6033903 Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors |
| 03/07/2000 | US6033868 In Vitro biosynthesis of proteins in native conformation |
| 03/07/2000 | US6033784 Method of photochemical immobilization of ligands using quinones |
| 03/07/2000 | US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby |
| 03/07/2000 | US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus |
| 03/07/2000 | US6033631 Synthesizer with reagent recycling |
| 03/02/2000 | WO2000011206A1 Methods and systems for predicting protein function |
| 03/02/2000 | WO2000011175A1 Genetic method for the expression of polyproteins in plants |
| 03/02/2000 | WO2000011032A2 Method for producing biostatin (tt-232 triacetate) and analogs thereof |
| 03/02/2000 | WO2000011031A1 Method for producing biostatin (tt-232 triacetate) and the analogs thereof |
| 03/02/2000 | WO2000011030A2 Method for chromatographically purifying insulins |
| 03/02/2000 | WO2000011023A2 Ring modified cyclic peptide analogs |
| 03/02/2000 | WO2000010584A1 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
| 03/02/2000 | WO1999064036A9 Novel therapeutic agents for macromolecular structures |
| 03/02/2000 | WO1999058476A3 Method and device for nonsynthetic deconvolution |
| 03/02/2000 | WO1999045947A9 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 03/02/2000 | WO1999037705A9 Block polymer processing for mesostructured inorganic oxide materials |
| 03/02/2000 | DE19940751A1 Apparatus for detecting light emissions comprises light-emitting matrix facing light-detection matrix, which together sandwich test substance |
| 03/02/2000 | DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes |
| 03/02/2000 | DE19838097A1 Verfahren zur chromatographischen Reinigung von Insulinen Method for the chromatographic purification of insulins |
| 03/02/2000 | CA2340676A1 Ring modified cyclic peptide analogs |
| 03/02/2000 | CA2340284A1 Methods and systems for predicting protein function |
| 03/02/2000 | CA2335379A1 Genetic method for the expression of polyproteins in plants |
| 03/01/2000 | EP0981599A2 Method for increasing yields or recombinant proteins |
| 03/01/2000 | EP0981368A1 Mass spectrometry of colonization factors |
| 03/01/2000 | EP0618926B1 New peptide derivatives |
| 02/29/2000 | US6031112 Process for the production of alkoxycarbonyl-dipeptides intermediates in the synthesis of the lisinopril |
| 02/29/2000 | US6031082 Treating protein mixture solution with a solid adsorption material, crystallizing protein, harvesting crystals; for fermentation broth |
| 02/29/2000 | US6031081 Process for reactivating purified membrane proteins by freezing them |
| 02/29/2000 | US6031074 Automated Peptide design and synthesis |
| 02/29/2000 | US6031073 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
| 02/29/2000 | US6030780 Screening drugs that modulate ability of signal transducers and activators of transcription protein dimers to interact and bind dna binding sites by measuring affinity of n-terminal domain to weak and strong binding sites |
| 02/29/2000 | US6030640 Oligoglycine compound, fibrous microtube of oligoglycine compound and process of producing fibrous microtube |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/24/2000 | WO2000009725A2 Method for recovering proteins from the interstitial fluid of plant tissues |
| 02/24/2000 | WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009559A1 Method for producing a balanced antibody composition and for purifying constituents of biological liquids |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009548A1 Chemical synthesis of exochelins |
| 02/24/2000 | WO2000009546A1 Process for the preparation of regular glycopeptides |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009540A1 Purification of blood clotting proteins |
| 02/24/2000 | WO2000009464A1 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 02/24/2000 | DE19836213A1 Elution of biomolecules, e.g. nucleic acids or proteins, from chromatographic media involves a mild polyol-containing eluant |
| 02/24/2000 | CA2349852A1 Method for recovering proteins from the interstitial fluid of plant tissues |
| 02/24/2000 | CA2340106A1 Purification of blood clotting proteins |
| 02/24/2000 | CA2339184A1 Chemical synthesis of exochelins |
| 02/23/2000 | EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges |
| 02/23/2000 | EP0980434A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/23/2000 | CN1245503A Oil bodies and associated proteins as affinity matrices |
| 02/22/2000 | US6028189 Solvent for oligonucleotide synthesis and methods of use |
| 02/22/2000 | US6028172 Reactor and method for solid phase peptide synthesis |
| 02/22/2000 | US6028168 Lanthionine bridged peptides |
| 02/22/2000 | US6027945 Methods of isolating biological target materials using silica magnetic particles |
| 02/22/2000 | US6027896 Providing a prognosis in subjects previously diagnosed with alzheimer's by identifying the apolipoprotein e type isoforms; then providing prognosis based on the presence or absence of an apolipoprotein e type 4 (apoe4) isoform |
| 02/22/2000 | US6027725 Multivalent antigen-binding proteins |
| 02/22/2000 | US6027720 G-CSF conjugate |
| 02/22/2000 | US6027650 Adsorption chromatography |
| 02/22/2000 | US6027648 A separating agent comprising a stationary phase in which ovomucoid part of which has been modified and a carrier on which the modified ovomucoid has been immobilized, contacting the separating agent with the mixture of optical isomers |
| 02/22/2000 | US6027565 Method and apparatus for crystalizing macromolecules in microgravity |
| 02/22/2000 | CA2004532C Peptide derivatives |
| 02/22/2000 | CA1340908C Methods of producing secreted receptor analogs and biologically active peptide dimers |
| 02/22/2000 | CA1340906C Fibronectin binding protein as well as its preparation |
| 02/17/2000 | DE19836615A1 Preparation of antibody composition useful for purifying components of biological fluids comprises immunizing animals with native and denatured protein fractions |
| 02/16/2000 | EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein |
| 02/16/2000 | EP0979245A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof |
| 02/16/2000 | EP0979243A2 Activation of peptides |
| 02/16/2000 | EP0979237A1 Method for removing viruses from protein solution by nanofiltration |
| 02/16/2000 | EP0979236A1 Apparatus for synthesis of oligomers, especially peptoids, with reagent recycling |
| 02/16/2000 | EP0832131B1 Separating unmodified hemoglobin from cross-linked hemoglobin |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244802A Reductive alkylation of glycopeptide antibiotics |
| 02/16/2000 | CN1049356C Protein-containing aqueous solutions |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |